BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31566136)

  • 1. Synergistic Effect of α-Solanine and Cisplatin Induces Apoptosis and Enhances Cell Cycle Arrest in Human Hepatocellular Carcinoma Cells.
    El-Daly SM; Gouhar SA; Gamal-Eldeen AM; Abdel Hamid FF; Ashour MN; Hassan NS
    Anticancer Agents Med Chem; 2019; 19(18):2197-2210. PubMed ID: 31566136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing S phase arrest and apoptosis.
    Liu FY; Wu YH; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Huang ZY
    Oncol Rep; 2014 Aug; 32(2):835-44. PubMed ID: 24919588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.
    Zhao JL; Zhao J; Jiao HJ
    Appl Biochem Biotechnol; 2014 Jan; 172(2):784-91. PubMed ID: 24122665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
    Dong X; Liu F; Li M
    Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells.
    Sudan S; Rupasinghe HP
    Anticancer Res; 2014 Apr; 34(4):1691-9. PubMed ID: 24692698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ethanolic Extract of Taiwanofungus camphoratus (Antrodia camphorata) Induces Cell Cycle Arrest and Enhances Cytotoxicity of Cisplatin and Doxorubicin on Human Hepatocellular Carcinoma Cells.
    Lin LT; Tai CJ; Su CH; Chang FM; Choong CY; Wang CK; Tai CJ
    Biomed Res Int; 2015; 2015():415269. PubMed ID: 26557666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Terpineol exhibits potent in vitro and in vivo anticancer effects in Hep-G2 hepatocellular carcinoma cells by suppressing cell migration and inducing apoptosis and sub-G1 cell cycle arrest.
    Liu S; Zhao Y; Cui HF; Cao CY; Zhang YB
    J BUON; 2016; 21(5):1195-1202. PubMed ID: 27837623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma.
    Wang Y; Liu Y; Liu Y; Zhou W; Wang H; Wan G; Sun D; Zhang N; Wang Y
    Int J Pharm; 2015 Apr; 483(1-2):89-100. PubMed ID: 25681730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV enhances cisplatin chemosensitivity in hepatocellular carcinoma by suppressing MRP2.
    Qu X; Gao H; Zhai J; Sun J; Tao L; Zhang Y; Song Y; Hu T
    Eur J Pharm Sci; 2020 May; 148():105325. PubMed ID: 32259679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
    Huo S; Yu H; Li C; Zhang J; Liu T
    Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomad Jellyfish
    Tawfik MM; Eissa N; Althobaiti F; Fayad E; Abu Almaaty AH
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of Raddeanin A and cisplatin induced therapeutic effect enhancement in human hepatocellular carcinoma.
    Li JN; Yu Y; Zhang YF; Li ZM; Cai GZ; Gong JY
    Biochem Biophys Res Commun; 2017 Apr; 485(2):335-341. PubMed ID: 28219642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines.
    Xu SP; Sun GP; Shen YX; Peng WR; Wang H; Wei W
    Acta Pharmacol Sin; 2007 Jun; 28(6):869-78. PubMed ID: 17506946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin B mediated scramblase activation triggers cytotoxicity and cell cycle arrest by andrographolide to overcome cellular resistance in cisplatin resistant human hepatocellular carcinoma HepG2 cells.
    Chowdhury KD; Sarkar A; Chatterjee S; Patra D; Sengupta D; Banerjee S; Chakraborty P; Sadhukhan GC
    Environ Toxicol Pharmacol; 2019 May; 68():120-132. PubMed ID: 30889542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid state fermentation process with Aspergillus kawachii enhances the cancer-suppressive potential of silkworm larva in hepatocellular carcinoma cells.
    Cho HD; Min HJ; Won YS; Ahn HY; Cho YS; Seo KI
    BMC Complement Altern Med; 2019 Sep; 19(1):241. PubMed ID: 31488109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 5-aryl-3-thiophen-2-yl-1H-pyrazoles as a new class of Hsp90 inhibitors in hepatocellular carcinoma.
    Mohamady S; Ismail MI; Mogheith SM; Attia YM; Taylor SD
    Bioorg Chem; 2020 Jan; 94():103433. PubMed ID: 31785857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allyl-isatin suppresses cell viability, induces cell cycle arrest, and promotes cell apoptosis in hepatocellular carcinoma HepG2 cells.
    Bian W; An Y; Qu H; Yang Y; Yang J; Xu Y
    Fundam Clin Pharmacol; 2016 Jun; 30(3):253-62. PubMed ID: 26945926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.